Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00154167 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of NV-101 in Dental Patients
A Phase 2 study, sponsored by Novalar Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 122
- Enrollment target
NCT00154167 is a Phase 2 study that has completed, run by Novalar Pharmaceuticals. The registered enrollment target is 122 participants.
The verdict
NCT00154167, a Phase 2 study, has completed, sponsored by Novalar Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 122 participants
- Enrollment target
Study Summary
The purpose of this study was: * to determine if NV-101 accelerates recovery from numbness compared to placebo * to evaluate safety of NV-101
Interventions
- DRUG NV-101 (phentolamine mesylate solution)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2003-02 |
| Est. Completion | 2003-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00154167
The ClinicalTrials.gov registry entry for NCT00154167 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novalar Pharmaceuticals, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NV-101 (phentolamine mesylate solution) is the first listed.
NCT00154167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00154167 about?
NCT00154167 is a clinical study titled "Safety and Efficacy Study of NV-101 in Dental Patients". The purpose of this study was: * to determine if NV-101 accelerates recovery from numbness compared to placebo * to evaluate safety of NV-101
What is the current status of trial NCT00154167?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 122 participants. The study started on 2003-02. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00154167?
The interventions under investigation include: NV-101 (phentolamine mesylate solution) (DRUG).
Who is sponsoring clinical trial NCT00154167?
This trial is sponsored by Novalar Pharmaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.